WEB ANNOUNCEMENT

Message from the Acting BARDA Director: 2020 BARDA Industry Week Wrap Up

About Image

 

Dear Stakeholders and Industry Partners,

It’s been a busy time at BARDA – but then, so has every week since the beginning of this pandemic. We know you’re busy, too! So our team wanted to thank you for attending BARDA Industry Day last week, and provide you with a 2020 BARDA Industry Week Wrap Up in case you missed some of the exciting news we shared earlier.

Thank you to everyone who attended our 1st ever Virtual BARDA Industry Day, where we saw our largest registration ever, with over 2,000 stakeholders registering. BARDA Industry Day is our annual event to engage with you, to communicate our strategic priorities for the coming fiscal year(s), and to hear from you. Despite being virtual, our team pushed hard to ensure we had as many live sessions as possible and to enable more industry partners to share their experience working with BARDA. Despite some technology lessons learned, it was a great opportunity to engage.

Thank you to everyone who reached out with positive comments on your experience and gave feedback on how we can continue to improve. For those who attended, we have sent out a post-event survey. Please complete the survey so we can continue to improve BARDA Industry Day. In the coming weeks, we will post all the BID videos online for those who did not attend or were unable to catch all the simultaneous sessions. I know I will be re-watching a few, too.

In case you missed it, we pushed out some new content on our website:

  • - BARDA’s new FDA Approval Page: Our new page celebrating 56 FDA approvals, licensures, and clearances for medical countermeasures supported by BARDA under novel public-  private partnerships with our industry partners. You can now explore all 56 approvals.
  • - BID2020 Sneak Peak: Two pagers developed by each BARDA division highlighting their strategic priorities, recent accomplishments, and future objectives. Read more here.
  • - OWS Award to Eli Lilly: Check out our recent award to Eli Lilly. Read the Web Announcement here.


Coming Up: This week, we will announce BARDA’s November "Innovation Project Spotlight”, a new series selected by one division each month that highlights exciting innovation happening in BARDA. Even during a pandemic, where COVID-19 is a high priority, I am proud that we can continue BARDA’s culture of innovation at both the project and program level. Explore our culture of innovation, see our October spotlight company selected by the DRIVe Division, and check back soon for our CBRN Division selection.

The last few months have been – and the months ahead will continue to be – challenging. We still need your help to develop new countermeasures and to help respond to this pandemic. Clinical volunteers for vaccine studies are still needed; we all need to continue to do our part. Learn more about how you can “Join the Fight, Be a Responder” by visiting our responder page.

Thank you for your continued commitment. From all of us at BARDA, we look forward to another great fiscal year working with you, our stakeholders, our partners, and our fellow Americans.

Thank you for your commitment, service, and dedication.

Gary Disbrow
Acting BARDA Director
Deputy Assistant Secretary

Last Updated: November 06, 2020
Website Refresh - www.medicalcountermeasures.gov is pleased to announce a phased launch of our newly redesigned public website. We are making website improvements to provide a more modern and customer-centric web experience. Over the next several months you will see differences throughout the site while we continue implementing updates. Thank you for your understanding and please let us know if you have any questions: techwatchinbox@hhs.gov